Although bone has a high potential to regenerate itself after damage and injury, the efficacious repair of large bone defects resulting from resection, trauma or non-union fractures still requires the implantation of bone grafts. Materials science, in conjunction with biotechnology, can satisfy these needs by developing artificial bones, synthetic substitutes and organ implants. In particular, recent advances in materials science have provided several innovations, underlying the increasing importance of biomaterials in this field. To address the increasing need for improved bone substitutes, tissue engineering seeks to create synthetic, three-dimensional scaffolds made from organic or inorganic materials, incorporating drugs and growth factors, to induce new bone tissue formation. This review emphasizes recent progress in materials science that allows reliable scaffolds to be synthesized for targeted drug delivery in bone regeneration, also with respect to past directions no longer considered promising. A general overview concerning modeling approaches suitable for the discussed systems is also provided.
CITATION STYLE
Ferracini, R., Martínez Herreros, I., Russo, A., Casalini, T., Rossi, F., & Perale, G. (2018, September 1). Scaffolds as structural tools for bone-targeted drug delivery. Pharmaceutics. MDPI AG. https://doi.org/10.3390/pharmaceutics10030122
Mendeley helps you to discover research relevant for your work.